Assistant Professor at Kharazmi Univrsity, Iran
Dr. Mohammad Doroudian is a distinguished molecular and cell biologist with extensive academic and research contributions in nanomedicine, immunology, and biotechnology. He currently serves as an Assistant Professor at Kharazmi University, Tehran, where he also directs international relations within the Faculty of Biological Sciences. With a research portfolio spanning over a decade, Dr. Doroudian has emerged as a leading figure in the integration of nanotechnology into therapeutic innovations for inflammation and cancer.
profile
scopus
Education
Dr. Doroudian earned his Ph.D. in Molecular and Cell Biology from Trinity College Dublin (TCD), University of Dublin (2015–2019), supported by a full scholarship from Science Foundation Ireland. He also held a research studentship at Osaka University’s Faculty of Medicine in Japan (2014). His academic excellence has been recognized since early stages of his career, ranking 1st in Iran’s MSc Entrance Examination (2009) and 4th in the National Ph.D. Entrance Exam (2013).
Experience
Dr. Doroudian has held multiple academic and leadership roles. Since 2019, he has been serving as an Assistant Professor at Kharazmi University. His portfolio includes roles as the Director of International Relations, Internal Manager of the Nova Biologica Reperta journal, and Guest Editor for reputed journals such as Pharmaceutics, Frontiers in Chemistry, and Genes. Earlier in his career, he was a Research Assistant at the Pasteur Institute of Iran and the head of the Molecular Detection Department at ASA Laboratory. Dr. Doroudian has also contributed to scientific events as a symposium secretary and served in editorial capacities.
Research Interests
Dr. Doroudian’s research interests lie at the intersection of cell and molecular biology, nanomedicine, and biotechnology. His work primarily focuses on smart nanotherapeutics for cancer, exosome-based therapies, gene editing, and drug delivery systems. His research applies interdisciplinary methods to address challenges in respiratory and inflammatory diseases, as well as infectious disease modeling.
Awards
He has received numerous accolades, including the Research Excellence Award from Kharazmi University (2024), Young Researcher Prize by Iran’s Vice-Presidency for Science and Technology (2022), and the Top Presentation Award at the 3rd Conference on Novel Achievements in Biology (2023). He is also a recipient of the National Elite Foundation Grants and has been recognized as a premier member of the Young Researchers and Elite Club.
Publications
Dr. Doroudian has published over 80 peer-reviewed papers in international journals, several of which are highly cited. Selected recent publications include:
Doroudian et al. (2024). Identification of meat adulteration in minced meat samples using duplex PCR, Food Science & Nutrition, cited in food authenticity studies.
Doroudian et al. (2023). Nano Based-Oncolytic Viruses for Cancer Therapy, Critical Reviews in Oncology/Hematology, referenced for viral nanotherapy.
Doroudian et al. (2023). Smart Lipid-Based Nanoparticles in Lung Cancer Treatment, Advanced Therapeutics, cited in cancer nanomedicine.
Doroudian et al. (2022). Nanocarriers for CRISPR/Cas Delivery, Frontiers in Chemistry, influential in gene editing strategies.
Doroudian et al. (2021). Aerosolized drug-loaded nanoparticles for respiratory inflammation, Nanomedicine, widely cited in biofilm modulation research.
Doroudian et al. (2020). Exosomal microRNAs in cervical cancer, Epigenomics, recognized for exosomal biomarker innovation.
Doroudian et al. (2018). Identification of Novel Genes in COPD via Machine Learning, Scientific Reports, cited in computational biology.
Conclusion
Dr. Mohammad Doroudian’s distinguished academic background, prolific research output, global collaboration, editorial leadership, and sustained national and international recognition mark him as an outstanding candidate for the Best Researcher Award. His contributions significantly advance the fields of molecular biology and nanomedicine, demonstrating both depth and innovation. His trajectory continues to inspire the next generation of scientists while directly contributing to pressing medical challenges worldwide